ArticleJHLT open2025
Advancing the frontier of left ventricular assist device outflow graft stenting: Stenting techniques and outcomes in a landmark case series.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Percutaneous Intervention in External Outflow Graft Obstruction of Magnetically Levitated Left Ventricular Assist Device: Long-Term Follow-Up and Quality of Life.Artificial organs · 2026Article
- Percutaneous management and outcomes of outflow graft obstruction in patients with left ventricular assist device: A single-center experience.JHLT open · 2026Article
- Successful Long-Term Outflow Graft Patency Restoration With a Stent-Graft Implantation in an LVAD Recipient.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left ventricular assist devices (LVADs) have demonstrated a significant mortality and quality-of-life benefit to patients with end-stage heart failure. However, a unique potential complication is outflow graft obstruction (OGO), in which the conduit between the LVAD pump and the aorta is narrowed. Recently, attempts at an endovascular approach with outflow graft stenting have been successful with comparatively low risk relative to surgical replacement of the LVAD. Because of the rarity of this event, optimal stenting technique and periprocedural management are unclear. Methods: In this series of 10 patients, we detail the percutaneous endovascular approach to OGO treatment. All cases were confirmed with contrasted computed tomography. Results: One patient experienced OGO recurrence and one patient had 2 recurrences, making the total interventions analyzed 13. The obstructions were either intrinsic, with accumulation of biodebris between the graft and the outer bend relief in 9 patients, or extrinsic from outflow graft kinking in 4 patients. All patients underwent successful outflow graft stenting confirmed by rapid restoration of pre-obstruction flow (12/13) or elimination of a pressure gradient across a site of suspected obstruction (1/13). Recurrence was observed in 3 instances. We further describe the stenting technique employed and how the unique nature of OGOs impacts the endovascular approach, and post-procedural outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.